Navigation Links
Genedata Celebrates 20 Years of Bioinformatics Innovations at Bio-IT World

Genedata, a leading provider of advanced software solutions for R&D, celebrates this month its 20th anniversary, marking the occasion with a strong presence at Bio-IT World Conference & Expo 2017 in Boston, MA. Genedata is sponsoring the meeting’s Welcome Reception and further extends an invitation to all attendees to view posters on the entire range of Genedata software platforms. Conference delegates are also invited to visit the Genedata booth (#238–240) at the Expo to discuss the latest developments in the company’s rapidly expanding software portfolio.

Genedata commenced operations on May 1, 1997 and has grown from a pioneering bioinformatics start-up to a team of more than 200 scientific and computational experts. The company, still headquartered in Basel, Switzerland, has established subsidiaries in the US, Germany, Japan and the UK, with plans to open additional offices around the world in the near future.

Genedata has evolved into a global leader in enterprise software systems for biopharmaceutical R&D based on a deep understanding of the underlying sciences and applied technologies and with a vision to enable the promise of precision medicine. Driven by the goal to improve the efficiency of the biopharmaceutical R&D process, today Genedata provides highly innovative software solutions for a variety of R&D workflows, such as in vitro screening, biologics discovery, bioprocess development, omics-based patient profiling and precise genome editing using for example CRISPR. Besides providing a range of integrative software platforms, the company has also established a consulting business that supports its clients in harmonizing and automating complex, large-scale experimental processes in order to maximize the ROI from their R&D.

Genedata was founded with the aim of providing software that meets the rapidly changing and expanding challenges of large-scale data analytics in R&D-driven companies. Today, the world’s leading biopharmaceutical and biotechnology companies, as well as some of the most innovative life science research institutions, rely on Genedata to improve R&D data quality, simplify R&D workflows through automation, and drive down the time and money expended on these tasks. Genedata software frequently produces time savings of over 90% and increases process productivity by orders of magnitude while significantly improving data quality. The speed with which comprehensive, actionable reports are produced using Genedata software facilitates efficient decision-making and potentially saves millions of dollars.

All Genedata products have been developed in partnership with leading life science companies and research institutions to ensure that they meet the real-life needs of R&D organizations. All products also continue to evolve and adapt to the changing needs of clients, driven by technological and organizational progress in R&D.

“Genedata is a science-driven company,” commented Dr. Othmar Pfannes, founder and CEO of Genedata. “Working with our clients, we identify data processing problems that are critical for R&D efficiency. Then we create software to solve these problems, putting in our scientific and technical expertise. That way, we remain highly relevant and truly meet our clients’ needs. We really enjoy the innovative and challenging aspects of our work.”

Genedata celebrates at Bio-IT World
Speaking just prior to opening the Welcome Reception, Dr. Pfannes stated, “We are delighted to be at Bio-IT World, an event that we have attended since its first conference some 15 years ago. I am humbled by the success of Genedata over the last two decades and am excited by the vast potential for growth in our key areas of operation—a potential that we will achieve by continuing to anticipate and meet the evolving challenges of this exciting industry.”

About Genedata
Genedata transforms data into intelligence with innovative software solutions and domain-specific consulting services that automate complex, large-scale experimental processes and enable organizations to maximize the ROI from their R&D. Founded in 1997, Genedata is headquartered in Switzerland and has offices in Germany, the UK, Japan, and the US.
Follow Us on LinkedIn

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
2. Genedata Screener 11 with Compound Combination Screening and Collaboration in the Cloud Announced at Bio-IT World 2013
3. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
4. AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization
5. New Genedata Expressionist for Mass Spectrometry Showcases at 2013 ASMS
6. Genedata at ESACT Announces Expansion Into Biopharma Process Development
7. Genedata Screener Extends Support for High-Throughput Thermofluor Assays
8. Genedata Screener Global User Group Meetings Will Examine Advancements in Plate-based Screening
9. Evonik and Genedata Broaden Their Collaboration with the Genedata Selector Biotechnology Data Management Platform
10. Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support
11. Biogas Consortium Using Genedata Selector for Metagenomics-based Process Optimization
Post Your Comments:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences ... the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and ... presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving Tree Wellness Center ... the needs of consumers who are incorporating medical marijuana into their wellness and ... , As operators of two successful Valley dispensaries, The Giving Tree’s two founders, ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... to 2025" report to their offering. ... The Global Biometric Vehicle Access System Market ... the next decade to reach approximately $1,580 million by 2025. ... for all the given segments on global as well as regional ...
Breaking Biology News(10 mins):